Pricing

Log inSign up

Prilenia

1 follower

‌

Prilenia is a clinical-stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders.

Industries

Biotechnology

Headquarters

Herzliya, Israel

Employees

11-50

Links

Org chart

Michael R. Hayden
CEO

Michael R. Hayden

Collapse
Henk Schuring
Chief Regulatory & Commercialization Officer
Limor Ben Har
COO
Anne Sullivan
Chief Business Officer
Yael Cohen
SVP, Head of Clinical Operations
Elena Berelovich
SVP, Head of CMC
Michal Geva
SVP, Head of Research
Rob Lauzen
Chief Financial Officer
Kristina Coppola
Head Of Corporate Communications

Teams

+3

Leadership Team

6 members

+2

Commercial Strategy Team

5 members

+1

Clinical Development Team

4 members

Offices

Similar companies

Gameto

4 followers

Synthekine

3 followers

Tango Therapeutics

2 followers

Caribou Biosciences

2 followers

Vera Therapeutics

2 followers

Neogene Therapeutics

2 followers

Kyverna Therapeutics

7 followers

Day One Biopharmaceuticals

1 follower

Apogee Therapeutics

1 follower

Cargo

1 follower

Aura Biosciences

1 follower

Explore companies